T. Satoh

 1,2-Fucosylated and  -N-acetylgalactosaminylated prostate-specific antigen as an efficient marker of prostatic cancer

Keiko Fukushima, T. Satoh, Shiro Baba et al. · Glycobiology · 2009 · 121 citations

Life Sciences, Biochemistry, Oncology +17

A Japanese Post-marketing Surveillance of Cetuximab (Erbitux(R)) in Patients with Metastatic Colorectal Cancer

Megumi Ishiguro, T. Watanabe, Kensei Yamaguchi et al. · Japanese Journal of Clinical Oncology · 2012 · 54 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +13

Multicenter Phase II Study of Cetuximab Plus Irinotecan in Metastatic Colorectal Carcinoma Refractory to Irinotecan, Oxaliplatin and Fluoropyrimidines

Makoto Tahara, Kuniaki Shirao, Narikazu Boku et al. · Japanese Journal of Clinical Oncology · 2008 · 37 citations

Medicine, Oncology, Pharmacology +17

High-dose-rate brachytherapy and hypofractionated external beam radiotherapy combined with long-term hormonal therapy for high-risk and very high-risk prostate cancer: outcomes after 5-year follow-up

Hiromichi Ishiyama, T. Satoh, Masashi Kitano et al. · Journal of Radiation Research · 2013 · 26 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Erythema Multiforme Induced by Sorafenib for Metastatic Renal Cell Carcinoma

Masaomi Ikeda, Tetsuo Fujita, Sumiyuki Mii et al. · Japanese Journal of Clinical Oncology · 2012 · 22 citations · Full text

Medicine, Dermatology, Oncology +17